Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives
10 mai 2024 17h40 HE
|
Tevogen Bio Inc
$50 million in financing advances operational objectives and bolsters a financial path to positive cashflow with minimal dilution.
Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”
09 mai 2024 10h00 HE
|
Science 37, Inc.
Science 37 announces its selection as the winner of the “Clinical Efficiency Innovation Award” in the 8th annual MedTech Breakthrough Awards program.
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
08 mai 2024 07h25 HE
|
ALTERITY THERAPEUTICS LIMITED
- ATH434-201 Trial on Track to Complete in November 2024 – - Top-Line Data Expected in January 2025 - MELBOURNE, Australia and SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) --...
Fragile X Syndrome Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
03 mai 2024 06h25 HE
|
Research and Markets
Dublin, May 03, 2024 (GLOBE NEWSWIRE) -- The "Fragile X Syndrome - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The analyst's clinical...
Global Graft Versus Host Disease (GVHD) Clinical Trials Review 2024
03 mai 2024 06h01 HE
|
Research and Markets
Dublin, May 03, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offering.This report will...
Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial
02 mai 2024 08h00 HE
|
Science 37, Inc.
Science 37's Metasite™ and Patient Recruitment Solutions together dramatically boost patient enrollment in a Phase 3 asthma clinical trial.
Clinical Trials Scorecard for Clinical Trial Investigations 2023-2024
01 mai 2024 09h42 HE
|
Research and Markets
Dublin, May 01, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trials: A Scorecard for Clinical Trial Investigations in 2023" report has been added to ResearchAndMarkets.com's offering.The clinical trials...
Phenylketonuria (PKU) Global Clinical Trials Review 2024: Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type
01 mai 2024 09h40 HE
|
Research and Markets
Dublin, May 01, 2024 (GLOBE NEWSWIRE) -- The "Phenylketonuria (Pku) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors
01 mai 2024 09h00 HE
|
H1
NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- H1, the digital health innovator on a mission to connect the world to the right doctors, today announced the appointment of Karen Walker to its Board of...
Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives
01 mai 2024 08h05 HE
|
Tevogen Bio Inc
For full year 2023, the operating expenses for Tevogen Bio Inc were $8.8 million.